Idexx Laboratories | IDXX - Selling And Administration Expenses

Stock Price
652.83
Daily Change
9.84 1.53%
Monthly
0.11%
Yearly
35.91%
Q3 Forecast
637.65

Idexx Laboratories reported $259.79M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 3.33B
Cash and Equivalent USD 164.59M
Cost of Sales USD 414.73M
Current Assets USD 1.36B
Current Liabilities USD 1.22B
Debt USD 1.24B
EBIT USD 373.05M
EBITDA USD 409.45M
Employees 11K
EPS Earnings Per Share USD 3.63
Equity Capital and Reserves USD -4.41B
Gross Profit on Sales USD 694.73M
Interest Expense on Debt USD 11.32M
Interest Income USD 627K
Loan Capital USD 449.81M
Market Capitalization USD 54.28B
Net Income USD 293.99M
Operating Expenses USD 736.41M
Operating Profit USD 373.05M
Ordinary Share Capital USD 80.42M
PE Price to Earnings USD 44.65
Pre-Tax Profit USD 362.35M
Sales Revenues USD 1.11B
Selling and Administration Expenses USD 259.79M
Stock USD 392.58M
Trade Creditors USD 116.59M
Trade Debtors USD 560.56M

Selling And Administration Expenses Change Date
Abbott USD 3.09B 39M Jun/2025
Align Technology USD 448.69M 1.06M Jun/2025
Dentsply International USD 334M 23M Jun/2025
Dexcom USD 328M 17.9M Jun/2025
Edwards Lifesciences USD 502M 36.3M Jun/2025
Fujifilm JPY 196.64B 1.13B Jun/2025
Globus Medical USD 303.62M 60.82M Jun/2025
Henry Schein USD 778M 42M Jun/2025
Hologic USD 251.3M 15.1M Jun/2025
Idexx Laboratories USD 259.79M 12M Jun/2025
Insulet USD 253.3M 7.3M Jun/2025
Integra LifeSciences USD 179.89M 15.88M Jun/2025
Intuitive Surgical USD 561.2M 2.2M Jun/2025
Masimo USD 138.9M 19.5M Jun/2025
Neogen USD 99.8M 22.72M May/2025
ResMed USD 265.12M 19.82M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Steris USD 353.8M 19.9M Jun/2025
Tandem Diabetes Care USD 93.05M 11.91M Jun/2025
Teleflex USD 215.08M 7.63M Jun/2025
Thermo Fisher Scientific USD 1.78B 58M Jun/2025
Zoetis USD 617M 54M Jun/2025